Your browser doesn't support javascript.
loading
ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma.
Rashid, Mamunur; van der Horst, Michiel; Mentzel, Thomas; Butera, Francesca; Ferreira, Ingrid; Pance, Alena; Rütten, Arno; Luzar, Bostjan; Marusic, Zlatko; de Saint Aubain, Nicolas; Ko, Jennifer S; Billings, Steven D; Chen, Sofia; Abi Daoud, Marie; Hewinson, James; Louzada, Sandra; Harms, Paul W; Cerretelli, Guia; Robles-Espinoza, Carla Daniela; Patel, Rajiv M; van der Weyden, Louise; Bakal, Chris; Hornick, Jason L; Arends, Mark J; Brenn, Thomas; Adams, David J.
Afiliação
  • Rashid M; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, CB10 1SA, UK.
  • van der Horst M; Department of Pathology, Maasstad Hospital, Maasstadweg 21, Rotterdam, 3079 DZ, The Netherlands.
  • Mentzel T; Dermatopathologie Friedrichshafen, Siemensstrasse 6/1, 88048, Friedrichshafen, Germany.
  • Butera F; Dynamical Cell Systems Laboratory. Chester Beatty Laboratories, Division of Cancer Biology. Institute of Cancer Research, London, SW3 6JB, UK.
  • Ferreira I; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, CB10 1SA, UK.
  • Pance A; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, CB10 1SA, UK.
  • Rütten A; Dermatopathologie Friedrichshafen, Siemensstrasse 6/1, 88048, Friedrichshafen, Germany.
  • Luzar B; Institute of Pathology, Medical Faculty University of Ljubljana, Korytkova 2, Ljubljana, 1000, Slovenia.
  • Marusic Z; University Hospital Center Zagreb, Kispaticeva 12, 10 000, Zagreb, Croatia.
  • de Saint Aubain N; Institut Jules Bordet, 121-125, boulevard de Waterloo, 1000, Brussels, Belgium.
  • Ko JS; Department of Pathology, Cleveland Clinic, Cleveland, OH, 44195, USA.
  • Billings SD; Department of Pathology, Cleveland Clinic, Cleveland, OH, 44195, USA.
  • Chen S; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, CB10 1SA, UK.
  • Abi Daoud M; Departments of Pathology & Laboratory Medicine and Medicine and The Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, T2L 2K8, Canada.
  • Hewinson J; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, CB10 1SA, UK.
  • Louzada S; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, CB10 1SA, UK.
  • Harms PW; Departments of Pathology and Dermatology, University of Michigan Medical School, 2800 Plymouth Road, Ann Arbor, MI, 48109-5602, USA.
  • Cerretelli G; Division of Pathology, Cancer Research UK Edinburgh Centre, The University of Edinburgh, Institute of Genetics & Molecular Medicine, Crewe Road, Edinburgh, EH4 2XR, UK.
  • Robles-Espinoza CD; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, CB10 1SA, UK.
  • Patel RM; Laboratorio Internacional de Investigación sobre el Genoma Humano, Universidad Nacional Autónoma de México, Campus Juriquilla, Blvd Juriquilla 3001, Santiago de Querétaro, 76230, Mexico.
  • van der Weyden L; Departments of Pathology and Dermatology, University of Michigan Medical School, 2800 Plymouth Road, Ann Arbor, MI, 48109-5602, USA.
  • Bakal C; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Cambridge, CB10 1SA, UK.
  • Hornick JL; Dynamical Cell Systems Laboratory. Chester Beatty Laboratories, Division of Cancer Biology. Institute of Cancer Research, London, SW3 6JB, UK.
  • Arends MJ; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
  • Brenn T; Division of Pathology, Cancer Research UK Edinburgh Centre, The University of Edinburgh, Institute of Genetics & Molecular Medicine, Crewe Road, Edinburgh, EH4 2XR, UK.
  • Adams DJ; Departments of Pathology & Laboratory Medicine and Medicine and The Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, T2L 2K8, Canada.
Nat Commun ; 10(1): 2213, 2019 05 17.
Article em En | MEDLINE | ID: mdl-31101826

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Quinases / Neoplasias das Glândulas Sudoríparas / Carcinoma Adenoide Cístico / Enzima Desubiquitinante CYLD Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Quinases / Neoplasias das Glândulas Sudoríparas / Carcinoma Adenoide Cístico / Enzima Desubiquitinante CYLD Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido